GUILENE DAVILMAR: Open Payments
NPI 1669994083 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 6 payments from 4 companies in 2025. Trend: 2023 $1,022 · 2024 $503 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $253 |
| ABBVIE INC. | 2 | $224 |
| Gilead Sciences, Inc. | 1 | $121 |
| Madrigal Pharmaceuticals | 1 | $115 |
Products named: TREMFYA, Livdelzi, SKYRIZI, REZDIFFRA, RINVOQ.
Industry payments across FL — which companies pay providers there.
